© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Armata Pharmaceuticals, Inc. (ARMP) shows an Average True Range (ATR) of 0.69 and an Enterprise Value of 197.22M. Its average trading volume over the past 3 months is 281.42K, indicating liquidity. These fundamental metrics provide insight into ARMP's underlying financial health and market activity.
Armata Pharmaceuticals, Inc. (ARMP) technical indicators as of December 22, 2025: the SMA 20 is -0.05%, SMA 50 at 8.34%, and SMA 200 at 104.12%. The RSI 14 value is 52.42, suggesting its current momentum. These technical analysis signals help assess ARMP's price trends and potential future movements.
Armata Pharmaceuticals, Inc. (ARMP) stock performance overview as of December 22, 2025: The 52-week high is $16.34 (currently -62.3% below), and the 52-week low is $0.898 (currently 585.89% above). Over the past year, ARMP's performance is 181.28%, compared to the S&P 500's 12.87% change.
According to market data, Armata Pharmaceuticals, Inc. (ARMP) stock's recent performance metrics show that over the last month, ARMP is -10.47%, with a Year-to-Date (YTD) performance of 232.97%. Over the past year, the stock has seen a 181.28% change. These figures summarize ARMP's price movements across various periods, reflecting its historical returns.
According to current financial data, ARMP stock's P/E (TTM) ratio is -4.97, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for ARMP, including P/S (60.09), P/B (-2.44), and P/FCF (-8.53), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.